Insider Trading Tracker: Live US Stock Disclosures & Insider Buying made on Feb 27, 2024

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
HF Sinclair Corp 10-year high	Carol Orme-Holding	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 57.34 per share.	27 Feb 2024	4,000,000	22,406,134 (13%)	2%	57.3	229,360,000	Common Stock
Aurora Innovation Inc (Class A)	Hoffman G. Reid	Director	Sale of securities on an exchange or to another person at price $ 2.52 per share.	27 Feb 2024	2,430,000	9,244,129	-	2.5	6,118,740	Class A Common Stock
Tonix Pharma Holding Corp	Seth Lederman	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	1,903,680	1,903,680	-		-	Stock Option
Tonix Pharma Holding Corp	Seth Lederman	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	1,903,680	1,903,680	-		-	Stock Option
TPG Inc (Class A)	Bonderman David	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	1,516,949	0	-	41.6	63,165,756	Class A Common Stock
TPG Inc (Class A)	Bonderman David	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	1,500,000	25,073,183	-		-	TPG Partners Holdings, L.P. Units
TPG Inc (Class A)	Bonderman David	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	1,500,000	1,516,949	-		0	Class A Common Stock
Tonix Pharma Holding Corp	Lederman Seth	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	1,309,911	1,309,911	-		-	Stock Option
Tonix Pharma Holding Corp	Seth Lederman	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	1,309,911	1,309,911	-		-	Stock Option
TPG Inc (Class A)	G. James Coulter	Director, Executive Chairman, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	1,266,949	0	-	41.6	52,755,756	Class A Common Stock
TPG Inc (Class A)	Coulter James G.	Director, Executive Chairman, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	1,250,000	34,880,900	-		-	TPG Partners Holdings, L.P. Units
TPG Inc (Class A)	G. Coulter James	Director, Executive Chairman, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	1,250,000	1,266,949	-		0	Class A Common Stock
Transocean Ltd	Frederik W. Mohn	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 4.89 per share.	27 Feb 2024	1,000,000	85,574,894 (13%)	0%	4.9	4,890,000	Registered Shares
TPG Inc (Class A)	J. Coslet Jonathan	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	1,000,000	10,823,496	-		-	TPG Partners Holdings, L.P. Units
TPG Inc (Class A)	Jon Winkelried	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	1,000,000	3,326,460	-	41.6	41,640,000	Class A Common Stock
TPG Inc (Class A)	J. Coslet Jonathan	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	1,000,000	1,000,000	-		0	Class A Common Stock
TPG Inc (Class A)	Jonathan J. Coslet	Director	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	1,000,000	0	-	41.6	41,640,000	Class A Common Stock
TPG Inc (Class A)	Jon Winkelried	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	1,000,000	11,307,878	-		-	TPG Partners Holdings, L.P. Units
TPG Inc (Class A)	Jon Winkelried	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	1,000,000	4,326,460	-		0	Class A Common Stock
TPG Inc (Class A)	Kelvin Davis L.	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	822,017	11,575,721	-		-	TPG Partners Holdings, L.P. Units
TPG Inc (Class A)	Kelvin L. Davis	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	822,017	1,666,601	-		0	Class A Common Stock
TPG Inc (Class A)	Kelvin Davis L.	Director	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	822,017	844,584	-	41.6	34,228,788	Class A Common Stock
CRISPR Therapeutics AG	George J. Simeon	Director	Grant, award, or other acquisition of securities at price $ 71.50 per share.	27 Feb 2024	769,196	769,196 (1%)	1%	71.5	54,997,514	Common Shares
American Airlines Grp Inc Results Board Meeting	Robert Isom D.	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	723,938	3,237,522 (0%)	0%		0	Common Stock
TPG Inc (Class A)	Sisitsky Todd B.	Director, President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	660,151	1,172,917	-		0	Class A Common Stock
TPG Inc (Class A)	B. Todd Sisitsky	Director, President	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	660,151	512,766	-	41.6	27,488,688	Class A Common Stock
TPG Inc (Class A)	Todd Sisitsky B.	Director, President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	660,151	10,626,796	-		-	TPG Partners Holdings, L.P. Units
Pfizer Dividend	Bourla Albert	Director, Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	644,640	644,640	-		-	Stock Appreciation Rights
Halliburton Results Board Meeting High Loss High Volume	Jefferey A. Miller	Director, Director, President & CEO	Grant, award, or other acquisition of securities at price $ 34.96 per share.	27 Feb 2024	621,600	1,380,615 (0%)	0%	35.0	21,731,136	Common Stock
Pfizer Dividend	Albert Bourla	Director, Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	569,600	569,600	-		-	Stock Appreciation Rights
Aurora Innovation Inc (Class A)	Hoffman G. Reid	Director	Sale of securities on an exchange or to another person at price $ 2.77 per share.	27 Feb 2024	533,024	11,674,129	-	2.8	1,478,129	Class A Common Stock
Envoy Medical Inc (Class A)	Glen A. Taylor	Director, Ten Percent Owner		27 Feb 2024	500,000	500,000	-		-	Warrant (right to buy)
Netgear Inc	Charles Prober	Director, Chief Exective Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	455,820	455,820	-		-	Performace Restricted Stock Units
Netgear Inc	Prober Charles	Director, Chief Exective Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	455,820	455,820 (1%)	1%		0	Common Stock
Netgear Inc	Charles Prober	Director, Chief Exective Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	455,820	455,820	-		-	Performace Restricted Stock Units
Netgear Inc	Charles Prober	Director, Chief Exective Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	455,820	455,820 (1%)	1%		0	Common Stock
Aligos Therapeutics Inc	Blatt Lawrence M.	Director, Chief Executive Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 Feb 2024	450,000	0	-		-	Stock Option (Right to Buy)
TPG Inc (Class A)	Jeffrey K. Rhodes	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	408,675	6,178,560	-		-	TPG Partners Holdings, L.P. Units
TPG Inc (Class A)	Rhodes Jeffrey K.	Director	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	408,675	176,492	-	41.6	17,017,227	Class A Common Stock
TPG Inc (Class A)	Jeffrey Rhodes K.	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	408,675	585,167	-		0	Class A Common Stock
Mind Medicine Inc	Robert B. Barrow	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	400,000	400,000	-		-	Stock Option (Right to Buy)
TPG Inc (Class A)	I. Trujillo David	Director	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	397,510	182,519	-	41.6	16,552,316	Class A Common Stock
TPG Inc (Class A)	Trujillo I. David	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	397,510	580,029	-		0	Class A Common Stock
TPG Inc (Class A)	Trujillo David I.	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	397,510	6,448,239	-		-	TPG Partners Holdings, L.P. Units
Tonix Pharma Holding Corp	Gregory M. Sullivan	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	358,000	358,000	-		-	Stock Option
Tonix Pharma Holding Corp	M. Sullivan Gregory	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	358,000	358,000	-		-	Stock Option
Aligos Therapeutics Inc	Blatt Lawrence M.	Director, Chief Executive Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 Feb 2024	323,400	0	-		-	Stock Option (Right to Buy)
Tonix Pharma Holding Corp	Jessica Edgar Morris	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	317,000	317,000	-		-	Stock Option
Tonix Pharma Holding Corp	Jessica Morris Edgar	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	317,000	317,000	-		-	Stock Option
Wells Fargo	W. Charles Scharf	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	314,862	314,862	-		-	2021 Performance Shares
TPG Inc (Class A)	Weingart Jack	Director, Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	308,468	1,084,450	-		0	Class A Common Stock
TPG Inc (Class A)	Weingart Jack	Director, Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	308,468	775,982	-	41.6	12,844,608	Class A Common Stock
TPG Inc (Class A)	Jack Weingart	Director, Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	308,468	4,020,817	-		-	TPG Partners Holdings, L.P. Units
Mondelez (Class A)	Dirk Van de Put	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	307,340	1,163,041 (0%)	0%		0	Class A Common Stock
Prothena Corporation plc	Kinney Gene G.	President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	307,000	307,000	-		-	Stock Option (Right to Buy)
Covenant Logistics Grp Inc (Class A) Results Board Meeting	R. Parker David	Director, Chairman and CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	300,000	300,000	-		-	Employee Stock Option (Right to Buy)
Olenox Industries Inc Results	Patricia Kaelin	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	300,000	360,000 (31%)	25%		0	Common Stock
Tonix Pharma Holding Corp	Bradley Saenger	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	282,000	282,000	-		-	Stock Option
Tonix Pharma Holding Corp	Bradley Saenger	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	282,000	282,000	-		-	Stock Option
Aligos Therapeutics Inc	Matthew McClure W.	Chief Medical Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 Feb 2024	255,626	0	-		-	Stock Option (Right to Buy)
TPG Inc (Class A)	Nehal Raj	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	250,858	3,351,225	-		-	TPG Partners Holdings, L.P. Units
TPG Inc (Class A)	Raj Nehal	Director	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	250,858	549,712	-	41.6	10,445,727	Class A Common Stock
TPG Inc (Class A)	Nehal Raj	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	250,858	800,570	-		0	Class A Common Stock
Everspin Tech Inc	Aggarwal Sanjeev	Director, PRESIDENT AND CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	250,000	494,650 (2%)	1%		0	Common Stock
Coinbase Global Inc (Class A)	Brian Armstrong	Director, Chairman and CEO, Ten Percent Owner		27 Feb 2024	250,000	250,000	-		0	Class A Common Stock
Ingersoll Rand	Reynal Vicente	Director, See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	240,000	456,974	-		-	Stock Options (Right to Buy)
Ingersoll Rand	Vicente Reynal	Director, See Remarks	Sale of securities on an exchange or to another person at price $ 90.16 per share.	27 Feb 2024	240,000	91,957 (0%)	0%	90.2	21,638,640	Common Stock
Ingersoll Rand	Vicente Reynal	Director, See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.61 per share.	27 Feb 2024	240,000	331,957 (0%)	0%	10.6	2,546,400	Common Stock
Tonix Pharma Holding Corp	Lederman Seth	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	235,320	235,320	-		-	Stock Option
Tonix Pharma Holding Corp	Seth Lederman	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	235,320	235,320	-		-	Stock Option
Aligos Therapeutics Inc	Lawrence M. Blatt	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	230,999	230,999	-		-	Stock Option (Right to Buy)
Under Armour Inc (Class A)	Linnartz C. Stephanie	Director, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	27 Feb 2024	221,507	1,638,797 (0%)	0%		0	Class C Common Stock
Halliburton Results Board Meeting High Loss High Volume	J. Mark Richard	President - Western Hemisphere	Grant, award, or other acquisition of securities at price $ 34.96 per share.	27 Feb 2024	218,800	592,576 (0%)	0%	35.0	7,649,248	Common Stock
CRISPR Therapeutics AG	George Simeon J.	Director	Grant, award, or other acquisition of securities at price $ 71.50 per share.	27 Feb 2024	216,578	216,578 (0%)	0%	71.5	15,485,327	Common Shares
Transdigm Group	Robert J. Small	Director	Sale of securities on an exchange or to another person at price $ 1160.50 per share.	27 Feb 2024	216,270	648,810 (1%)	0%	1160.5	250,981,335	Common Stock
Brookdale Senior Living Inc	Lucinda M. Baier	Director, President and CEO		27 Feb 2024	215,964	2,919,476 (1%)	0%	5.9	1,276,347	Common Stock
Pfizer Dividend	Dolsten Mikael	President R&D		27 Feb 2024	214,880	214,880	-		-	Stock Appreciation Rights
MetLife	Khalaf Michel A.	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	206,752	625,273 (0%)	0%		-	Common Stock
Aligos Therapeutics Inc	Symons Julian A.	See Remarks	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 Feb 2024	200,000	0	-		-	Stock Option (Right to Buy)
Pfizer Dividend	Mikael Dolsten	President R&D		27 Feb 2024	189,867	189,867	-		-	Stock Appreciation Rights
Nu Skin Enterprises Inc (Class A)	S. Napierski Ryan	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	189,574	356,117 (0%)	0%		0	Class A Common Stock
Karyopharm Therapeutics Inc	Mason Michael	EVP, CFO & Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	188,205	432,605 (0%)	0%		0	Common Stock
Overseas Shipholding Group Inc	Norton H. Samuel	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	178,283	2,446,579 (2%)	0%		0	Class A Common Stock
Aligos Therapeutics Inc	Lesley Ann Calhoun	See Remarks	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 Feb 2024	176,237	0	-		-	Stock Option (Right to Buy)
Wells Fargo	P. Santomassimo Michael	Sr. EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	175,117	175,117	-		-	2021 Performance Shares
Halliburton Results Board Meeting High Loss High Volume	Pope J. Lawrence	EVP Administration & CHRO	Grant, award, or other acquisition of securities at price $ 34.96 per share.	27 Feb 2024	173,000	484,841 (0%)	0%	35.0	6,048,080	Common Stock
TPG Inc (Class A)	Ganendran Sarvananthan	Director	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	172,705	42,388	-	41.6	7,191,436	Class A Common Stock
Halliburton Results Board Meeting High Loss High Volume	Van H. Beckwith	EVP, Secretary and CLO	Grant, award, or other acquisition of securities at price $ 34.96 per share.	27 Feb 2024	170,400	360,961 (0%)	0%	35.0	5,957,184	Common Stock
Halliburton Results Board Meeting High Loss High Volume	Carre J. Eric	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 34.96 per share.	27 Feb 2024	168,800	307,828 (0%)	0%	35.0	5,901,248	Common Stock
TPG Inc (Class A)	Sarvananthan Ganendran	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	162,707	215,093	-		0	Class A Common Stock
TPG Inc (Class A)	Sarvananthan Ganendran	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	162,707	1,368,619	-		-	TPG Partners Holdings, L.P. Units
Pfizer Dividend	Chris Boshoff	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	161,160	161,160	-		-	Stock Appreciation Rights
Pfizer Dividend	Denton David M.	Chief Financial Officer & EVP	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	161,160	161,160	-		-	Stock Appreciation Rights
Pfizer Dividend	Malik Aamir	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	161,160	161,160	-		-	Stock Appreciation Rights
Diamondrock Hospitality Co. 10-year high	W. Mark Brugger	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	157,347	2,567,681 (1%)	0%		0	Common stock, par value $0.01 per share
NovoCure Ltd Results Board Meeting	Ashley Cordova	Chief Financial Officer		27 Feb 2024	156,348	156,348	-		-	Stock Options (Right to buy)
NovoCure Ltd Results Board Meeting	Frank Leonard	EVP, Pres., Novocure Oncology	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	156,348	156,348	-		-	Stock Options (Right to buy)
Diamondrock Hospitality Co. 10-year high	Brugger Mark W.	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.18 per share.	27 Feb 2024	152,360	2,415,321 (1%)	0%	9.2	1,398,665	Common stock, par value $0.01 per share
Moderna	Bancel Stephane	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	151,943	151,943	-		-	Stock Option (Right to Buy)
Everspin Tech Inc	Anuj Aggarwal	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	150,000	322,824 (1%)	0%		0	Common Stock
Mind Medicine Inc	Dan Karlin	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	150,000	150,000	-		-	Stock Option (Right to Buy)
Mind Medicine Inc	Greenway L. Schond	Chief Financial Officer		27 Feb 2024	150,000	150,000	-		-	Stock Option (Right to Buy)
Elanco Animal Health Inc	N. Simmons Jeffrey	Director, PRESIDENT, CEO AND DIRECTOR	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	148,084	1,293,269 (0%)	0%		0	Common Stock
Credo Tech Grp Holding Ltd	Yat Tung Lam	Director, Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 22.86 per share.	27 Feb 2024	146,165	1,206,400	-	22.9	3,341,127	Ordinary Shares
Shoals Tech Grp Inc (Class A)	Brandon Moss	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	142,950	245,909	-		0	Class A Common Stock
Pfizer Dividend	Denton David M.	Chief Financial Officer & EVP	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	142,400	142,400	-		-	Stock Appreciation Rights
Pfizer Dividend	Boshoff Chris	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	142,400	142,400	-		-	Stock Appreciation Rights
Pfizer Dividend	Aamir Malik	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	142,400	142,400	-		-	Stock Appreciation Rights
Aurora Innovation Inc (Class A)	Reid Hoffman G.	Director	Sale of securities on an exchange or to another person at price $ 2.52 per share.	27 Feb 2024	135,000	513,563	-	2.5	339,930	Class A Common Stock
Aurora Innovation Inc (Class A)	Hoffman G. Reid	Director	Sale of securities on an exchange or to another person at price $ 2.52 per share.	27 Feb 2024	135,000	513,564	-	2.5	339,930	Class A Common Stock
Aligos Therapeutics Inc	M. Blatt Lawrence	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	132,352	132,352	-		-	Stock Option (Right to Buy)
Ligand Pharma Inc (Class B)	C. Davis Todd	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	131,723	131,723	-		-	Employee Stock Option (right to buy)
Wells Fargo	Powell Scott E.	SEVP & Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	130,025	130,025	-		-	2021 Performance Shares
American International	Zaffino Peter S.	Director, Chairman & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.95 per share.	27 Feb 2024	128,435	505,420 (0%)	0%	71.9	9,240,898	Common Stock
Pfizer Dividend	M. Douglas Lankler	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	125,347	125,347	-		-	Stock Appreciation Rights
Pfizer Dividend	Michael McDermott	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	125,347	125,347	-		-	Stock Appreciation Rights
NovoCure Ltd Results Board Meeting	Ben Arye Barak	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	125,078	125,078	-		-	Stock Options (Right to buy)
NovoCure Ltd Results Board Meeting	Weinberg Uri	Chief Innovation Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	125,078	125,078	-		-	Stock Options (Right to buy)
Mind Medicine Inc	Wernli Miri Halperin	Executive President		27 Feb 2024	125,000	125,000	-		-	Stock Option (Right to Buy)
Mind Medicine Inc	Mark R. Sullivan	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	125,000	125,000	-		-	Stock Option (Right to Buy)
Wells Fargo	Weiss G. Jonathan	Sr. Executive Vice President		27 Feb 2024	124,296	124,296	-		-	2021 Performance Shares
Driven Brands Holdings Inc	Fitzpatrick Jonathan	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	121,998	2,454,361	-		0	Common Stock
Mondelez (Class A)	Dirk Van de Put	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.13 per share.	27 Feb 2024	121,723	1,041,318 (0%)	0%	73.1	8,901,603	Class A Common Stock
Great Elm Grp Inc	W. Jason Reese	Director, See remarks, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 1.92 per share.	27 Feb 2024	120,000	6,280,346 (24%)	0%	1.9	230,400	Common stock, par value $0.01 per share ("Common Stock")
Hartford Insurance Results Board Meeting	Swift Christopher J.	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	116,414	116,414	-		-	Stock Option
Teradata Corp	Steve McMillan	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	115,128	643,430 (0%)	0%		0	Common Stock
MetLife	A. Khalaf Michel	Director, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.16 per share.	27 Feb 2024	113,305	511,968 (0%)	0%	69.2	7,836,174	Common Stock
Pfizer Dividend	McDermott Michael	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	110,756	110,756	-		-	Stock Appreciation Rights
Pfizer Dividend	Lankler M. Douglas	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	110,756	110,756	-		-	Stock Appreciation Rights
NovoCure Ltd Results Board Meeting	Michal Nath Puri	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	109,443	109,443	-		-	Stock Options (Right to buy)
Goodyear Tire & Rubber Co.	Wells R. Darren	EVP & Chief Admin. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	108,236	0	-		-	2017 Plan Option
Goodyear Tire & Rubber Co.	R. Darren Wells	EVP & Chief Admin. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.12 per share.	27 Feb 2024	108,236	258,677 (0%)	0%	10.1	1,095,348	Common Stock
Eastman Chemical	J. Costa Mark	Director, CEO & Board Chair	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	108,139	108,139	-		-	Employee Stock Option (right to buy)
Omnicell Inc	A. Randall Lipps	Director, CHAIRMAN, PRESIDENT AND CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	107,251	210,451 (0%)	0%		0	Common Stock
Wyndham Hotels & Resorts Inc Results Board Meeting	Geoffrey A. Ballotti	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	105,611	404,746 (0%)	0%		0	Common Stock
Aligos Therapeutics Inc	Lesley Calhoun Ann	See Remarks	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 Feb 2024	105,000	0	-		-	Stock Option (Right to Buy)
Aligos Therapeutics Inc	A. Julian Symons	See Remarks	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 Feb 2024	105,000	0	-		-	Stock Option (Right to Buy)
Coinbase Global Inc (Class A)	Brock J. Lawrence	Chief People Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.71 per share.	27 Feb 2024	104,758	118,314	-	18.7	1,960,022	Class A Common Stock
Coinbase Global Inc (Class A)	J. Lawrence Brock	Chief People Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	104,758	78,762	-		-	Employee Stock Option (right to buy)
NeuroPace Inc	Joel Becker	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	104,720	104,720	-		-	Stock Option (Right to Buy)
NovoCure Ltd Results Board Meeting	Ashley Cordova	Chief Financial Officer		27 Feb 2024	102,249	219,867 (0%)	0%	16.3	1,666,659	Ordinary Shares
NovoCure Ltd Results Board Meeting	Frank Leonard	EVP, Pres., Novocure Oncology	Grant, award, or other acquisition of securities at price $ 16.30 per share.	27 Feb 2024	102,249	164,695 (0%)	0%	16.3	1,666,659	Ordinary Shares
TPG Inc (Class A)	Anilu Vazquez-Ubarri	Director, Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	101,937	435,648	-		0	Class A Common Stock
TPG Inc (Class A)	Anilu Vazquez-Ubarri	Director, Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	101,937	1,574,878	-		-	TPG Partners Holdings, L.P. Units
TPG Inc (Class A)	Anilu Vazquez-Ubarri	Director, Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	101,937	333,711	-	41.6	4,244,657	Class A Common Stock
Sterling infra Inc	Cutillo Joseph A.	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	100,250	764,958 (2%)	0%		0	Common Stock
Coinbase Global Inc (Class A)	M. Choi Emilie	President & COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	100,000	1,208,513	-		-	Employee Stock Option (right to buy)
Coinbase Global Inc (Class A)	M. Emilie Choi	President & COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.71 per share.	27 Feb 2024	100,000	337,051	-	18.7	1,871,000	Class A Common Stock
Ingersoll Rand	Vicente Reynal	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	100,000	100,000	-		-	Stock Options (Right to Buy)
Mind Medicine Inc	Carrie Liao F.	Chief Accounting Officer		27 Feb 2024	100,000	100,000	-		-	Stock Option (Right to Buy)
Goodyear Tire & Rubber Co.	R. Darren Wells	EVP & Chief Admin. Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.82 per share.	27 Feb 2024	99,727	158,950 (0%)	0%	11.8	1,178,803	Common Stock
AMC Networks Inc (Class A)	A. Dolan Kristin	Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	99,109	106,580 (0%)	0%		0	Class A Common Stock
AMC Networks Inc (Class A)	A. Kristin Dolan	Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	99,109	198,216	-		-	Restricted Stock Units
MetLife	A. Michel Khalaf	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	97,614	97,614	-		-	Employee Stock Options (right to buy)
Snowflake Inc (Class A)	Frank Slootman	Director, CEO and Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	93,969	274,112	-		0	Class A Common Stock
Vishay Intertechnology Inc	Smejkal Joel	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	93,907	169,136 (0%)	0%		0	Common Stock
Wells Fargo	Ather Williams	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	93,396	93,396	-		-	2021 Performance Shares
PubMatic Inc Ordinary Shares	Goel Rajeev K.	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner		27 Feb 2024	93,270	210,984	-		-	Class B Common Stock
PubMatic Inc Ordinary Shares	K. Rajeev Goel	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner		27 Feb 2024	93,270	93,270	-		0	Class A Common Stock
PubMatic Inc Ordinary Shares	Rajeev K. Goel	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	93,270	304,254	-		-	Class B Common Stock
PubMatic Inc Ordinary Shares	Rajeev Goel K.	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	93,270	637,475	-		-	Stock Option (Right to buy Class B Common Stock)
Banc of California Inc Results Board Meeting	Wolff M. Jared	Director, PRESIDENT AND CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	92,041	143,572 (0%)	0%		0	Common Stock
Aligos Therapeutics Inc	Matthew W. McClure	Chief Medical Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 Feb 2024	92,000	0	-		-	Stock Option (Right to Buy)
TPG Inc (Class A)	Bradford Berenson	General Counsel		27 Feb 2024	90,895	287,147	-		0	Class A Common Stock
TPG Inc (Class A)	Bradford Berenson	General Counsel		27 Feb 2024	90,895	1,434,518	-		-	TPG Partners Holdings, L.P. Units
TPG Inc (Class A)	Berenson Bradford	General Counsel		27 Feb 2024	90,895	196,252	-	41.6	3,784,868	Class A Common Stock
Jefferies Fin Grp Inc	B. Richard Handler	Director, CEO	Grant, award, or other acquisition of securities at price $ 41.26 per share.	27 Feb 2024	90,790	16,686,049 (5%)	0%	41.3	3,745,995	Common Stock
Overseas Shipholding Group Inc	Norton Samuel H.	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	90,042	83,739	-		-	Performance Restricted Stock Units
Overseas Shipholding Group Inc	Samuel H. Norton	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	90,042	94,544	-		-	Performance Restricted Stock Units
Pfizer Dividend	de Germay Alexandre	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	89,533	89,533	-		-	Stock Appreciation Rights
Altria Group	Gifford William F.	Director, Chief Executive Officer		27 Feb 2024	88,718	625,216 (0%)	0%		0	Common Stock
Mondelez (Class A)	Luca Zaramella	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	88,200	299,589 (0%)	0%		0	Class A Common Stock
Wells Fargo	Patterson Ellen R.	Sr. EVP and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	87,559	87,559	-		-	2021 Performance Shares
Axsome Therapeutics Inc	Tabuteau Herriot	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	87,192	87,192	-		-	Employee Stock Option (Right to Buy)
Prothena Corporation plc	Garren Hideki	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	85,000	85,000	-		-	Stock Option (Right to Buy)
Prothena Corporation plc	Wagner M. Zago	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	85,000	85,000	-		-	Stock Option (Right to Buy)
Prothena Corporation plc	D. Karp Carol	Chief Regulatory Officer		27 Feb 2024	85,000	85,000	-		-	Stock Option (Right to Buy)
Prothena Corporation plc	Nguyen B. Tran	Chief Strategy Officer and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	85,000	85,000	-		-	Stock Option (Right to Buy)
Prothena Corporation plc	Smith Brandon S.	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	85,000	85,000	-		-	Stock Option (Right to Buy)
Prothena Corporation plc	Michael Malecek J.	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	85,000	85,000	-		-	Stock Option (Right to Buy)
Parsons Corp	Smith A. Carey	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	82,934	401,195 (0%)	0%		0	Common Stock
Biomarin pharma Inc - Registered Shares	Jean-Jacques Bienaime	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	82,700	502,302 (0%)	0%		0	Common Stock
NovoCure Ltd Results Board Meeting	Uri Weinberg	Chief Innovation Officer	Grant, award, or other acquisition of securities at price $ 16.30 per share.	27 Feb 2024	81,799	171,148 (0%)	0%	16.3	1,333,324	Ordinary Shares
NovoCure Ltd Results Board Meeting	Barak Arye Ben	General Counsel	Grant, award, or other acquisition of securities at price $ 16.30 per share.	27 Feb 2024	81,799	117,122 (0%)	0%	16.3	1,333,324	Ordinary Shares
Aligos Therapeutics Inc	Lawrence M. Blatt	Director, Chief Executive Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 Feb 2024	80,850	0	-		-	Stock Option (Right to Buy)
Samsara Inc (Class A) Board Meeting	Bicket John	Director, SEE REMARKS, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 33.73 per share.	27 Feb 2024	80,654	379,518	-	33.7	2,720,855	Class A Common Stock
Samsara Inc (Class A) Board Meeting	Biswas Sanjit	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 33.74 per share.	27 Feb 2024	80,342	385,993	-	33.7	2,710,378	Class A Common Stock
Datadog Inc (Class A)	Olivier Pomel	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	80,252	379,327 (0%)	0%		0	Class A Common Stock
Datadog Inc (Class A)	Amit Agarwal	PRESIDENT	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	80,252	327,323 (0%)	0%		0	Class A Common Stock
Datadog Inc (Class A)	Le-Quoc Alexis	Director, CHIEF TECHNOLOGY OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	80,252	327,580 (0%)	0%		0	Class A Common Stock
Pfizer Dividend	Alexandre de Germay	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	79,111	79,111	-		-	Stock Appreciation Rights
NovoCure Ltd Results Board Meeting	Nicholas Leupin	Chief Medical Officer		27 Feb 2024	78,174	78,174	-		-	Stock Options (Right to buy)
NovoCure Ltd Results Board Meeting	Giladi Moshe	Chief Science Officer		27 Feb 2024	78,174	78,174	-		-	Stock Options (Right to buy)
Aligos Therapeutics Inc	McClure Matthew W.	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	75,183	75,183	-		-	Stock Option (Right to Buy)
Aligos Therapeutics Inc	Ann Lesley Calhoun	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	74,998	74,998	-		-	Stock Option (Right to Buy)
Aligos Therapeutics Inc	Symons Julian A.	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	74,998	74,998	-		-	Stock Option (Right to Buy)
TPG Inc (Class A)	Chorengel Maya	Director	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	74,773	57,146	-	41.6	3,113,548	Class A Common Stock
Pfizer Dividend	Alexandre de Germay	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	74,377	74,377 (0%)	0%		0	Common Stock
NovoCure Ltd Results Board Meeting	Groenhuysen C. M. Wilhelmus	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	71,920	71,920	-		-	Stock Options (Right to buy)
MetLife	John McCallion D.	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	71,915	244,558 (0%)	0%		-	Common Stock
Pfizer Dividend	Sahni Payal	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	71,627	71,627	-		-	Stock Appreciation Rights
NovoCure Ltd Results Board Meeting	Nath Michal Puri	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 16.30 per share.	27 Feb 2024	71,574	109,167 (0%)	0%	16.3	1,166,656	Ordinary Shares
Wells Fargo	Saul Van Beurden	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	70,048	70,048	-		-	2021 Performance Shares
Graphic Packaging Holding Co	Joseph P. Yost	EVP & President, International	Sale of securities on an exchange or to another person at price $ 26.20 per share.	27 Feb 2024	70,000	205,231 (0%)	0%	26.2	1,834,000	Common Stock
TPG Inc (Class A)	Chorengel Maya	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	69,298	887,791	-		-	TPG Partners Holdings, L.P. Units
TPG Inc (Class A)	Chorengel Maya	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	69,298	131,919	-		0	Class A Common Stock
Nu Skin Enterprises Inc (Class A)	Chayce Clark D.	EVP and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	69,116	158,175 (0%)	0%		0	Class A Common Stock
Pfizer Dividend	Sally Susman	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	68,045	68,045	-		-	Stock Appreciation Rights
Pfizer Dividend	Fonseca L. Lidia	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	68,045	68,045	-		-	Stock Appreciation Rights
Aligos Therapeutics Inc	Matthew W. McClure	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	65,713	65,713	-		-	Stock Option (Right to Buy)
Bloomin Brands Inc	Deno David J.	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	65,386	65,386	-		-	Restricted Stock Units
Elanco Animal Health Inc	Jeffrey Simmons N.	Director, PRESIDENT, CEO AND DIRECTOR	Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.46 per share.	27 Feb 2024	64,527	1,228,742 (0%)	0%	16.5	1,062,114	Common Stock
PubMatic Inc Ordinary Shares	Rajeev Goel K.	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 20.44 per share.	27 Feb 2024	64,257	41,843	-	20.4	1,313,612	Class A Common Stock
Wells Fargo	Barry Sommers	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	64,210	64,210	-		-	2021 Performance Shares
Mondelez (Class A)	P. Gruber Vinzenz	EVP and President, Europe		27 Feb 2024	64,140	275,566 (0%)	0%		0	Class A Common Stock
West Pharma Services Results Board Meeting	Mark Green Eric	Director, President, CEO and Board Chair	Sale of securities on an exchange or to another person at price $ 359.85 per share.	27 Feb 2024	64,132	152,908 (0%)	0%	359.9	23,077,971	Common Stock
West Pharma Services Results Board Meeting	Mark Eric Green	Director, President, CEO and Board Chair	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	64,132	15,684	-		-	Stock Option (Right to Buy)
West Pharma Services Results Board Meeting	Eric Green Mark	Director, President, CEO and Board Chair	Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.38 per share.	27 Feb 2024	64,132	217,040 (0%)	0%	57.4	3,679,894	Common Stock
Pfizer Dividend	Sahni Payal	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	63,289	63,289	-		-	Stock Appreciation Rights
CRISPR Therapeutics AG	Simeon J. George	Director	Grant, award, or other acquisition of securities at price $ 71.50 per share.	27 Feb 2024	63,177	63,177 (0%)	0%	71.5	4,517,156	Common Shares
Etsy Inc Analyst Downgrade	Silverman Joshua G.	Director, PRESIDENT & CEO	Sale of securities on an exchange or to another person at price $ 72.50 per share.	27 Feb 2024	63,047	23,140 (0%)	0%	72.5	4,570,908	Common Stock
Etsy Inc Analyst Downgrade	Joshua G. Silverman	Director, PRESIDENT & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.62 per share.	27 Feb 2024	63,047	86,187 (0%)	0%	10.6	669,559	Common Stock
Etsy Inc Analyst Downgrade	Silverman G. Joshua	Director, PRESIDENT & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	63,047	1,702,278	-		-	Employee Stock Option (Right to Buy)
Everspin Tech Inc	Schrenk David	VP SALES & BUS. DEVELOPMENT		27 Feb 2024	63,000	120,767 (0%)	0%		0	Common Stock
MetLife	Bill Pappas	EVP, Global Tech. & Ops.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	62,924	119,160 (0%)	0%		-	Common Stock
MetLife	Ramy Tadros	President, U.S. Business	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	62,924	188,464 (0%)	0%		-	Common Stock
MoonLake Immunotherapeutics (Class A)	Jorge Santos da Silva	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 55.00 per share.	27 Feb 2024	62,810	3,043,619	-	55	3,454,550	Class A ordinary shares, par value $0.0001 per share
Wells Fargo	Daley M William	Vice Chairman - Public Affairs		27 Feb 2024	62,652	62,652	-		-	2021 Performance Shares
vTv Therapeutics Inc (Class A)	Steven L. Tuch	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	62,159	74,659	-		-	Employee stock option (right to buy)
Pacific Gas & Electric Results Board Meeting	Kaled Awada	EVP, Chief People Officer		27 Feb 2024	60,278	60,288 (0%)	0%		0	Common Stock
Moderna	James M Mock	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	60,216	60,216	-		-	Stock Option (Right to Buy)
Moderna	Shannon Klinger Thyme	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	60,216	60,216	-		-	Stock Option (Right to Buy)
Datadog Inc (Class A)	David Obstler	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	60,189	306,198 (0%)	0%		0	Class A Common Stock
Pfizer Dividend	L. Fonseca Lidia	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	60,124	60,124	-		-	Stock Appreciation Rights
Pfizer Dividend	Sally Susman	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	60,124	60,124	-		-	Stock Appreciation Rights
Arch Capital	Grandisson Marc	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	59,247	59,247	-		-	Stock Option (right to buy)
Fifth Third Bancorp Rising EPS	Robert P. Shaffer	EVP and Chief Risk Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	58,875	186,712 (0%)	0%		0	Common Stock
Fifth Third Bancorp Rising EPS	Schramm A. Jude	EVP & CIO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	58,875	144,422 (0%)	0%		0	Common Stock
Fifth Third Bancorp Rising EPS	Jamie C. Leonard	EVP & Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	58,875	255,844 (0%)	0%		0	Common Stock
Aligos Therapeutics Inc	Symons Julian A.	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	58,822	58,822	-		-	Stock Option (Right to Buy)
Bloomin Brands Inc	David Deno J.	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	58,800	0	-		-	Stock Option (right to buy)
Bloomin Brands Inc	J. Deno David	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.32 per share.	27 Feb 2024	58,800	766,482 (0%)	0%	25.3	1,488,816	Common Stock
Ligand Pharma Inc (Class B)	E.	PRESIDENT & CHIEF OPERATING	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	58,544	58,544	-		-	Employee Stock Option (right to buy)
Aligos Therapeutics Inc	Blatt Lawrence M.	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	57,749	57,749	-		-	Stock Option (Right to Buy)
Agios Pharma Inc High Loss High Volume	P. David Schenkein	Director		27 Feb 2024	57,471	0	-		-	Stock option (right to buy)
Agios Pharma Inc High Loss High Volume	Schenkein P. David	Director		27 Feb 2024	57,471	122,854 (0%)	0%	34.9	2,005,163	Common stock
Agios Pharma Inc High Loss High Volume	David Schenkein P.	Director		27 Feb 2024	57,471	180,325 (0%)	0%	31.6	1,818,382	Common stock
Credo Tech Grp Holding Ltd	Tung Lam Yat	Director, Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 22.92 per share.	27 Feb 2024	57,278	1,575,521	-	22.9	1,312,943	Ordinary Shares
Datadog Inc (Class A)	Sean Walters Michael	CHIEF REVENUE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	56,846	203,285 (0%)	0%		0	Class A Common Stock
Bloomin Brands Inc	David J. Deno	Director, CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.14 per share.	27 Feb 2024	56,409	710,073 (0%)	0%	27.1	1,530,940	Common Stock
MoonLake Immunotherapeutics (Class A)	Santos da Silva Jorge	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 55.00 per share.	27 Feb 2024	56,065	2,987,554	-	55	3,083,575	Class A ordinary shares, par value $0.0001 per share
Diamondrock Hospitality Co. 10-year high	Jeffrey J. Donnelly	EVP & Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.18 per share.	27 Feb 2024	55,257	363,760 (0%)	0%	9.2	507,259	Common stock, par value $0.01 per share
Wyndham Hotels & Resorts Inc Results Board Meeting	Ballotti Geoffrey A.	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.50 per share.	27 Feb 2024	54,022	350,724 (0%)	0%	77.5	4,186,705	Common Stock
Prothena Corporation plc	L. Walker Karin	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	54,000	54,000	-		-	Stock Option (Right to Buy)
Overseas Shipholding Group Inc	Trueblood Richard L.	VP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	53,483	397,625 (0%)	0%		0	Class A Common Stock
TPG Inc (Class A)	Sisitsky B. Todd	Director, President	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	52,807	396,982	-	41.6	2,198,883	Class A Common Stock
NeuroPace Inc	Becker Joel	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	52,470	52,470	-		0	Common Stock
Vishay Intertechnology Inc	Marc Zandman	Director, ExecChairman & Chief Bus Dev	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	52,308	94,939 (0%)	0%		0	Common Stock
Aligos Therapeutics Inc	Lesley Calhoun Ann	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	51,833	51,833	-		-	Stock Option (Right to Buy)
Lantern Pharma Inc	W. Kreis Leslie	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 4.85 per share.	27 Feb 2024	51,608	463,804	-	4.9	250,299	Common Stock
Fox Factory Holding Corp	Dennison Michael C.	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	51,364	130,737 (0%)	0%		0	Common Stock
NovoCure Ltd Results Board Meeting	Leupin Nicholas	Chief Medical Officer		27 Feb 2024	51,124	51,124 (0%)	0%	16.3	833,321	Ordinary Shares
NovoCure Ltd Results Board Meeting	Giladi Moshe	Chief Science Officer		27 Feb 2024	51,124	69,771 (0%)	0%	16.3	833,321	Ordinary Shares
Shoals Tech Grp Inc (Class A)	Dominic Bardos	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	50,910	117,835	-		0	Class A Common Stock
Datadog Inc (Class A)	Adam Blitzer	CHIEF OPERATING OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	50,158	224,395 (0%)	0%		0	Class A Common Stock
Indie Semiconductor Inc (Class A)	McClymont Donald	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	50,000	5,639,506	-		0	Class V Common Stock
Indie Semiconductor Inc (Class A)	Donald McClymont	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 6.25 per share.	27 Feb 2024	50,000	76,750	-	6.3	312,500	Class A Common Stock
Indie Semiconductor Inc (Class A)	McClymont Donald	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	50,000	5,639,506	-		-	ADK Class A Units
Indie Semiconductor Inc (Class A)	McClymont Donald	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	50,000	126,750	-		0	Class A Common Stock
Medpace Holdings Inc Results Board Meeting	August Troendle J.	Director, CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 401.88 per share.	27 Feb 2024	50,000	5,183,019 (14%)	0%	401.9	20,094,000	Common Stock
Medpace Holdings Inc Results Board Meeting	Troendle J. August	Director, CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 404.13 per share.	27 Feb 2024	50,000	5,133,019 (14%)	0%	404.1	20,206,500	Common Stock
South Plains Fin Inc	Curtis Griffith C.	Director, Chairman and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 25.00 per share.	27 Feb 2024	50,000	1,253,797 (6%)	0%	25	1,250,000	Common Stock
South Plains Fin Inc	Valles G. Noe	Director	Purchase of securities on an exchange or from another person at price $ 25.00 per share.	27 Feb 2024	50,000	245,512 (1%)	0%	25	1,250,000	Common Stock
Trupanion Inc	Rawlings Darryl Graham Andrew	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	50,000	50,000	-		-	Restricted Stock Unit (RSU)
Trupanion Inc	Margi Tooth	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	50,000	50,000	-		-	Restricted Stock Unit (RSU)
Snowflake Inc (Class A)	Kleinerman Christian	EVP, Product Management	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	49,832	774,899	-		0	Class A Common Stock
Diamondrock Hospitality Co. 10-year high	Jeffrey Donnelly J.	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	49,827	419,017 (0%)	0%		0	Common stock, par value $0.01 per share
Coinbase Global Inc (Class A)	Lawrence Brock J.	Chief People Officer	Sale of securities on an exchange or to another person at price $ 204.98 per share.	27 Feb 2024	49,710	13,556	-	205.0	10,189,476	Class A Common Stock
American International	David McElroy	EVP, Chairman, General Ins	Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.95 per share.	27 Feb 2024	49,426	136,474 (0%)	0%	72.0	3,556,201	Common Stock
Coinbase Global Inc (Class A)	Choi Emilie M.	President & COO	Sale of securities on an exchange or to another person at price $ 204.98 per share.	27 Feb 2024	49,266	237,051	-	205.0	10,098,456	Class A Common Stock
PubMatic Inc Ordinary Shares	Mukul Kumar	PRESIDENT, ENGINEERING		27 Feb 2024	49,000	126,600	-		-	Class B Common Stock
PubMatic Inc Ordinary Shares	Mukul Kumar	PRESIDENT, ENGINEERING		27 Feb 2024	49,000	73,582	-		0	Class A Common Stock
Ingersoll Rand	Vicente Reynal	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	48,726	48,726	-		-	Stock Options (Right to Buy)
Pitney Bowes Inc	James Arthur Fairweather	EVP & Chief Innovation Officer		27 Feb 2024	48,706	251,001 (0%)	0%		0	Common Stock
Pitney Bowes Inc	Fairweather James Arthur	EVP & Chief Innovation Officer		27 Feb 2024	48,706	97,413	-		-	Restricted Stock Units
Pitney Bowes Inc	Dies C. Jason	Interim CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	48,706	97,413	-		-	Restricted Stock Units
Pitney Bowes Inc	C. Jason Dies	Interim CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	48,706	267,274 (0%)	0%		0	Common Stock
Mondelez (Class A)	Laura Stein	EVP, CLA and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	48,120	78,813 (0%)	0%		0	Class A Common Stock
Teleflex Incorporated	Kelly Liam J.	Director, Chairman, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	48,094	48,094	-		-	Stock Option / (Right to Buy)
Teleflex Incorporated	Liam J. Kelly	Director, Chairman, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	48,094	48,094	-		-	Stock Option / (Right to Buy)
Axsome Therapeutics Inc	Tabuteau Herriot	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	47,886	47,886	-		-	Restricted Stock Units
Chefs` Warehouse Inc	Pappas Christopher	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	47,788	2,401,670 (7%)	0%		-	Common Stock
Coinbase Global Inc (Class A)	Ehrsam Ernest Frederick	Director, Ten Percent Owner		27 Feb 2024	47,429	6,490,273	-		-	Class B Common Stock
Coinbase Global Inc (Class A)	Ehrsam Frederick Ernest	Director, Ten Percent Owner		27 Feb 2024	47,429	47,429	-		0	Class A Common Stock
Overseas Shipholding Group Inc	O’Halloran Patrick J.	VP & Chief Operations Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	47,244	375,159 (0%)	0%		0	Class A Common Stock
Overseas Shipholding Group Inc	Damon Mote	VP & Chief Admin Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	47,244	374,750 (0%)	0%		0	Class A Common Stock
Diamondrock Hospitality Co. 10-year high	G. Troy Furbay	EVP & Chief Investment Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	47,205	615,799 (0%)	0%		0	Common stock, par value $0.01 per share
NovoCure Ltd Results Board Meeting	C. M. Wilhelmus Groenhuysen	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 16.30 per share.	27 Feb 2024	47,034	256,862 (0%)	0%	16.3	766,654	Ordinary Shares
PubMatic Inc Ordinary Shares	Mukul Kumar	PRESIDENT, ENGINEERING	Sale of securities on an exchange or to another person at price $ 20.35 per share.	27 Feb 2024	46,886	26,696	-	20.3	953,938	Class A Common Stock
Huron Consulting Grp Inc	Roth H. James	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	46,288	114,328 (0%)	0%		0	Common Stock
Snowflake Inc (Class A)	Scarpelli Michael P.	Chief Financial Officer		27 Feb 2024	46,272	187,300	-		0	Class A Common Stock
Teradata Corp	Bramley Claire	Chief Financial Officer		27 Feb 2024	46,051	162,660 (0%)	0%		0	Common Stock
iRhythm Tech Inc	S. Blackford Quentin	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	45,268	173,778 (0%)	0%		0	Common Stock
UFP Ind Inc	Matthew J. Missad	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 113.49 per share.	27 Feb 2024	45,235	368,346 (0%)	0%	113.5	5,133,720	Common Stock
Overseas Shipholding Group Inc	Norton Samuel H.	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.27 per share.	27 Feb 2024	44,191	2,402,388 (2%)	0%	5.3	232,887	Class A Common Stock
Moderna	Stephen Hoge	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	43,894	43,894	-		-	Stock Option (Right to Buy)
Wells Fargo	Derek Flowers A.	Sr. EVP and Chief Risk Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	43,779	43,779	-		-	2021 Performance Shares
USA Compression Partners LP - Unit	Eric Long D.	Director, See Remarks	Sale of securities on an exchange or to another person at price $ 24.58 per share.	27 Feb 2024	43,725	312,346 (0%)	0%	24.6	1,074,761	Common Units
Nu Skin Enterprises Inc (Class A)	D. Thomas James	Chief Financial Officer		27 Feb 2024	43,444	73,642 (0%)	0%		0	Class A Common Stock
Mondelez (Class A)	Carlos Gustavo Valle	EVP and President, NA	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	42,760	62,245 (0%)	0%		0	Class A Common Stock
Coursera Inc Results Board Meeting	F. Belsky Leah	Chief Revenue Officer	Sale of securities on an exchange or to another person at price $ 16.29 per share.	27 Feb 2024	42,756	837,338	-	16.3	696,589	Common Stock
Snowflake Inc (Class A)	W. Degnan Christopher	Chief Revenue Officer		27 Feb 2024	42,713	137,050	-		0	Class A Common Stock
Diamondrock Hospitality Co. 10-year high	Furbay G. Troy	EVP & Chief Investment Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.18 per share.	27 Feb 2024	42,154	573,645 (0%)	0%	9.2	386,974	Common stock, par value $0.01 per share
Chefs` Warehouse Inc	Christopher Pappas	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.78 per share.	27 Feb 2024	41,239	2,360,431 (7%)	0%	37.8	1,558,009	Common Stock
Driven Brands Holdings Inc	W. Ferrera Gary	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	41,174	104,275	-		0	Common Stock
Casella Waste Systems Inc (Class A)	W. Casella John	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	40,803	52,102 (0%)	0%		0	Class A Common Stock
American International	Kevin Hogan T.	CEO, Corebridge Financial, Inc	Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.95 per share.	27 Feb 2024	40,572	267,431 (0%)	0%	71.9	2,919,155	Common Stock
Diamondrock Hospitality Co. 10-year high	William J. Tennis	EVP & General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.18 per share.	27 Feb 2024	39,660	461,552 (0%)	0%	9.2	364,079	Common stock, par value $0.01 per share
Nu Skin Enterprises Inc (Class A)	Steven Keith Hatchett	Chief Product Officer		27 Feb 2024	39,495	96,603 (0%)	0%		0	Class A Common Stock
TPG Inc (Class A)	Martin Davidson	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	39,317	620,513	-		-	TPG Partners Holdings, L.P. Units
TPG Inc (Class A)	Martin Davidson	Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	39,317	30,991	-	41.6	1,637,160	Class A Common Stock
TPG Inc (Class A)	Davidson Martin	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	39,317	70,308	-		0	Class A Common Stock
Shoals Tech Grp Inc (Class A)	Tolnar Jeffery	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	38,987	99,141	-		0	Class A Common Stock
Hartford Insurance Results Board Meeting	A. Bombara Beth	EVP and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.25 per share.	27 Feb 2024	38,915	118,083 (0%)	0%	41.3	1,605,244	Common Stock
Hartford Insurance Results Board Meeting	A. Bombara Beth	EVP and CFO	Sale of securities on an exchange or to another person at price $ 95.42 per share.	27 Feb 2024	38,915	69,168 (0%)	0%	95.4	3,713,226	Common Stock
Hartford Insurance Results Board Meeting	Beth Bombara A.	EVP and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	38,915	0	-		-	Stock Option
AMC Networks Inc (Class A)	Kristin A. Dolan	Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.73 per share.	27 Feb 2024	38,811	67,769 (0%)	0%	12.7	494,064	Class A Common Stock
Pfizer Dividend	Johnson A. Rady	Executive Vice President		27 Feb 2024	38,678	38,678	-		-	Stock Appreciation Rights
Exlservice Hldgs Inc	Bhalla Vikas	EVP & Head of Outsourcing	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	38,316	38,316	-		-	Restricted Stock Units
Exlservice Hldgs Inc	Vivek Jetley	EVP and Head of Analytics	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	38,316	38,316	-		-	Restricted Stock Units
Pitney Bowes Inc	Chadwick Maria Ana	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	38,052	76,103	-		-	Restricted Stock Units
Pitney Bowes Inc	Maria Chadwick Ana	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	38,052	103,501 (0%)	0%		0	Common Stock
Omnicell Inc	E. Etta Nchacha	EVP & CFO		27 Feb 2024	37,853	76,999 (0%)	0%		0	Common Stock
Akebia Therapeutics Inc	Butler P. John	Director, CEO and President	Sale of securities on an exchange or to another person at price $ 1.52 per share.	27 Feb 2024	37,733	2,091,150 (1%)	0%	1.5	57,354	Common Stock
Transdigm Group	Small Robert J.	Director	Sale of securities on an exchange or to another person at price $ 1160.50 per share.	27 Feb 2024	37,620	121,238 (0%)	0%	1160.5	43,658,010	Common Stock
Parsons Corp	Smith Carey A.	Director, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.54 per share.	27 Feb 2024	37,404	363,791 (0%)	0%	80.5	3,012,518	Common Stock
Coinbase Global Inc (Class A)	Armstrong Brian	Director, Chairman and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 207.75 per share.	27 Feb 2024	37,401	25,699	-	207.7	7,769,975	Class A Common Stock
CBL& Associates Properties Inc - Ordinary Shares - New	Lebovitz Stephen D.	Director, CEO	Sale of securities on an exchange or to another person at price $ 23.54 per share.	27 Feb 2024	37,255	423,600	-	23.5	877,121	Common Stock
Coinbase Global Inc (Class A)	Brian Armstrong	Director, Chairman and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 201.94 per share.	27 Feb 2024	37,095	212,905	-	201.9	7,491,079	Class A Common Stock
Mondelez (Class A)	Zaramella Luca	EVP & Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.13 per share.	27 Feb 2024	37,035	262,554 (0%)	0%	73.1	2,708,370	Class A Common Stock
Arista Networks	Duda Kenneth	Director, CTO and SVP Software Eng.	Other type of transaction at price $ 0.00 per share.	27 Feb 2024	36,888	268,098 (0%)	0%		0	Common Stock
Sterling infra Inc	Cutillo Joseph A.	Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.22 per share.	27 Feb 2024	36,499	728,459 (2%)	0%	106.2	3,876,924	Common Stock
First Commonwealth Fin Corp	Price Michael T.	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	36,450	374,014 (0%)	0%		0	Common Stock
Elanco Animal Health Inc	Young Todd S.	SEE REMARKS		27 Feb 2024	36,440	124,357 (0%)	0%		0	Common Stock
U.S. GoldMining Inc	Smith Tim	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	36,000	36,000	-		-	Stock Options
Ocular Therapeutix Inc Board Meeting	Richard L. Lindstrom	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	36,000	36,000	-		-	Stock Option (Right to Buy)
Biomarin pharma Inc - Registered Shares	Jean-Jacques Bienaime	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	35,975	538,277 (0%)	0%		0	Common Stock
MetLife	Debel Marlene	EVP & Chief Risk Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	35,957	127,454 (0%)	0%		-	Common Stock
Coinbase Global Inc (Class A)	Armstrong Brian	Director, Chairman and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 203.79 per share.	27 Feb 2024	35,948	153,317	-	203.8	7,326,015	Class A Common Stock
Amneal Pharma Inc (Class A)	Nikita Shah	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	35,620	0	-		-	Restricted Stock Units
Amneal Pharma Inc (Class A)	Nikita Shah	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	35,620	355,592 (0%)	0%		-	Class A Common Stock
Snowflake Inc (Class A)	Czajkowski Grzegorz	EVP, Engineering and Support	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	35,594	87,316	-		0	Class A Common Stock
Natera Inc	Daniel Rabinowitz	SEC. AND CHIEF LEGAL OFFICER	Sale of securities on an exchange or to another person at price $ 75.09 per share.	27 Feb 2024	35,307	204,218 (0%)	0%	75.1	2,651,298	Common Stock
Shoals Tech Grp Inc (Class A)	Peetz Mehgan	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	35,121	108,361	-		0	Class A Common Stock
Driven Brands Holdings Inc	Rivera Daniel	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	35,074	548,917	-		0	Common Stock
Coinbase Global Inc (Class A)	Armstrong Brian	Director, Chairman and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 205.82 per share.	27 Feb 2024	34,840	92,142	-	205.8	7,170,943	Class A Common Stock
Lantern Pharma Inc	W. Kreis Leslie	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 4.40 per share.	27 Feb 2024	34,731	515,412	-	4.4	152,816	Common Stock
MetLife	John McCallion D.	EVP & Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.16 per share.	27 Feb 2024	34,613	209,945 (0%)	0%	69.2	2,393,835	Common Stock
PubMatic Inc Ordinary Shares	Rajeev K. Goel	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 21.19 per share.	27 Feb 2024	34,343	7,500	-	21.2	727,653	Class A Common Stock
Strategic Education Inc	Karl McDonnell	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	34,189	195,548 (0%)	0%		0	Common Stock
Strategic Education Inc	Robert S. Silberman	Director, CHAIRMAN	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	34,189	277,772 (1%)	0%		0	Common Stock
MACOM Tech Soln Holdings Inc	Susan Ocampo	Director, Ten Percent Owner		27 Feb 2024	34,186	6,886,661 (10%)	0%	88	3,008,368	Common Stock
Pfizer Dividend	Johnson A. Rady	Executive Vice President		27 Feb 2024	34,176	34,176	-		-	Stock Appreciation Rights
Diamondrock Hospitality Co. 10-year high	J. William Tennis	EVP & General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	34,093	501,212 (0%)	0%		0	Common stock, par value $0.01 per share
Teradata Corp	Ashton Hillary	Chief Product Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	34,078	166,447 (0%)	0%		0	Common Stock
TPG Inc (Class A)	Jon Winkelried	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	33,899	0	-	41.6	1,411,554	Class A Common Stock
TPG Inc (Class A)	Coulter James G.	Director, Executive Chairman, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	33,899	0	-	41.6	1,411,554	Class A Common Stock
TPG Inc (Class A)	Bonderman David	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 41.64 per share.	27 Feb 2024	33,899	0	-	41.6	1,411,554	Class A Common Stock
Datadog Inc (Class A)	de Armelle Madre	CHIEF PEOPLE OFFICER		27 Feb 2024	33,439	122,159 (0%)	0%		0	Class A Common Stock
Overseas Shipholding Group Inc	Allan Susan	VP, General Counsel & Corp Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	33,348	300,728 (0%)	0%		0	Class A Common Stock
Axsome Therapeutics Inc	Jacobson Mark	CHIEF OPERATING OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	32,825	32,825	-		-	Employee Stock Option (Right to Buy)
Meta Cloud Deal	Zuckerberg Mark	Director, COB and CEO, Ten Percent Owner		27 Feb 2024	32,794	688,450	-		-	Class B Common Stock
Meta Cloud Deal	Zuckerberg Mark	Director, COB and CEO, Ten Percent Owner		27 Feb 2024	32,794	670,794 (0%)	0%		0	Class A Common Stock
MetLife	Tadros Ramy	President, U.S. Business	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.16 per share.	27 Feb 2024	32,636	155,828 (0%)	0%	69.2	2,257,106	Common Stock
MetLife	McCallion D. John	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	32,538	32,538	-		-	Employee Stock Options (right to buy)
MetLife	A. Michel Khalaf	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	32,534	418,521 (0%)	0%		-	Common Stock
Ligand Pharma Inc (Class B)	C. Davis Todd	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	32,436	104,145 (0%)	0%		0	Common Stock
Halliburton Results Board Meeting High Loss High Volume	Jones Myrtle L.	Senior Vice Pres - Tax		27 Feb 2024	32,400	75,793 (0%)	0%	35.0	1,132,704	Common Stock
Alphatec Holdings Inc	Sponsel P. David	EVP, SALES	Sale of securities on an exchange or to another person at price $ 15.19 per share.	27 Feb 2024	32,365	622,296 (1%)	0%	15.2	491,624	Common Stock
Halliburton Results Board Meeting High Loss High Volume	Charles Geer	SVP & Chief Accounting Officer		27 Feb 2024	32,200	111,354 (0%)	0%	35.0	1,125,712	Common Stock
Snowflake Inc (Class A)	Dageville Benoit	Director, President of Products	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	32,034	71,773	-		0	Class A Common Stock
Omnicell Inc	Corey J. Manley	EVP&CHIEF LEGAL/ADMIN OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	31,965	51,035 (0%)	0%		0	Common Stock
FTI Consulting Inc Results Board Meeting	H. Gunby Steven	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 216.59 per share.	27 Feb 2024	31,943	308,594 (0%)	0%	216.6	6,918,534	Common Stock
MoonLake Immunotherapeutics (Class A)	Kristian Reich	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 55.00 per share.	27 Feb 2024	31,910	2,925,573	-	55	1,755,050	Class A ordinary shares, par value $0.0001 per share
Eastman Chemical	Brad A. Lich	EVP & CCO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	31,773	31,773	-		-	Employee Stock Option (right to buy)
Amneal Pharma Inc (Class A)	S. Andrew Boyer	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	31,663	276,402 (0%)	0%		-	Class A Common Stock
Amneal Pharma Inc (Class A)	Andrew S. Boyer	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	31,663	0	-		-	Restricted Stock Units
Custom Truck One Source Inc	Fredrick M. Ross	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	31,588	181,777 (0%)	0%		0	Common Stock
Meta Cloud Deal	Zuckerberg Mark	Director, COB and CEO, Ten Percent Owner		27 Feb 2024	31,493	295,507,110	-		-	Class B Common Stock
Meta Cloud Deal	Zuckerberg Mark	Director, COB and CEO, Ten Percent Owner		27 Feb 2024	31,493	31,493 (0%)	0%		0	Class A Common Stock
Halliburton Results Board Meeting High Loss High Volume	M Timothy McKeon	Senior VP and Treasurer	Grant, award, or other acquisition of securities at price $ 34.96 per share.	27 Feb 2024	31,400	86,426 (0%)	0%	35.0	1,097,744	Common Stock
Alphatec Holdings Inc	Lish Scott	CHIEF OPERATING OFFICER	Sale of securities on an exchange or to another person at price $ 15.19 per share.	27 Feb 2024	31,075	507,165 (0%)	0%	15.2	472,029	Common Stock
Vishay Intertechnology Inc	Zandman Marc	Director, ExecChairman & Chief Bus Dev	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	31,047	99,832 (0%)	0%		0	Common Stock
Coinbase Global Inc (Class A)	Lawrence Brock J.	Chief People Officer	Sale of securities on an exchange or to another person at price $ 202.69 per share.	27 Feb 2024	30,650	70,508	-	202.7	6,212,442	Class A Common Stock
Biomarin pharma Inc - Registered Shares	Henry Fuchs J.	President, Worldwide R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	30,640	224,894 (0%)	0%		0	Common Stock
Huron Consulting Grp Inc	C. Mark Hussey	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	30,318	128,604 (0%)	0%		0	Common Stock
Murphy Oil Corp	W Utsch Louis	Vice President	Sale of securities on an exchange or to another person at price $ 39.94 per share.	27 Feb 2024	30,260	9,504 (0%)	0%	39.9	1,208,687	Common Stock
Aligos Therapeutics Inc	Bridget Martell A.	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 Feb 2024	30,000	0	-		-	Stock Option (Right to Buy)
Aligos Therapeutics Inc	Scopa James	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 Feb 2024	30,000	0	-		-	Stock Option (Right to Buy)
MetLife	Bill Pappas	EVP, Global Tech. & Ops.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.16 per share.	27 Feb 2024	29,959	89,201 (0%)	0%	69.2	2,071,964	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made made on Feb 27, 2024

Monitor US insider transactions and discover insider buying and selling of stocks on Feb 27, 2024.

The latest disclosure under SEC insider trading regulations was reported by HF Sinclair Corporation., where the revocation of 4,000,000 Common Stock of common stock was executed at an average price of $57.3. This transaction was reported to the Securities and Exchange Commission on Feb. 27, 2024.

Screeners based on Insider Trading parameters